188 related articles for article (PubMed ID: 10586980)
1. Use of a PCR-based assay for fetal Cw antigen genotyping in a patient with a history of moderately severe hemolytic disease of the newborn due to anti-Cw.
Reiner AP; Teramura G; Aramaki KM
Am J Perinatol; 1999; 16(6):277-81. PubMed ID: 10586980
[TBL] [Abstract][Full Text] [Related]
2. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation.
Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA
Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127
[TBL] [Abstract][Full Text] [Related]
3. Maternal CW alloimmunization.
Bowman JM; Pollock J
Vox Sang; 1993; 64(4):226-30. PubMed ID: 8517051
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies.
Hromadnikova I; Vesela K; Benesova B; Nekovarova K; Duskova D; Vlk R; Spalova I; Gerychova R; Hakenova A; Rosenbaumova Z; Vlasin P; Vlachova A; Palasek V; Roznakova E; Calda P
Prenat Diagn; 2005 Dec; 25(12):1079-83. PubMed ID: 16231295
[TBL] [Abstract][Full Text] [Related]
5. [Prenatal genotyping of the RhD locus by polymerase chain reaction in fetus at risk of hemolytic disease].
Misković B; Stipoljev F; Hadzisejdić I; Grahovac B
Lijec Vjesn; 2008; 130(1-2):4-6. PubMed ID: 18589635
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the RhD genotype in fetuses at risk for RhD hemolytic disease.
Spence WC; Maddalena A; Demers DB; Bick DP
Obstet Gynecol; 1995 Feb; 85(2):296-8. PubMed ID: 7824249
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive fetal RhD genotyping from maternal blood.
Kolialexi A; Tounta G; Mavrou A
Expert Rev Mol Diagn; 2010 Apr; 10(3):285-96. PubMed ID: 20370586
[TBL] [Abstract][Full Text] [Related]
8. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D.
Pirelli KJ; Pietz BC; Johnson ST; Pinder HL; Bellissimo DB
Prenat Diagn; 2010 Dec; 30(12-13):1207-12. PubMed ID: 21072752
[TBL] [Abstract][Full Text] [Related]
9. Preliminary results of fetal Rhc examination in plasma of pregnant women with anti-c.
Orzińska A; Guz K; Brojer E; Zupańska B
Prenat Diagn; 2008 Apr; 28(4):335-7. PubMed ID: 18382999
[TBL] [Abstract][Full Text] [Related]
10. [Rh system genotyping in amniotic fluid].
Cotorruelo C; Biondi C; García Borrás S; Di Mónaco R; Martino W; Racca A
Medicina (B Aires); 2001; 61(1):76-8. PubMed ID: 11265629
[TBL] [Abstract][Full Text] [Related]
11. Severe hemolytic disease of the newborn caused by anti-Gonzales antibody.
Leschek E; Pearlman SA; Boudreaux I; Meek R
Am J Perinatol; 1993 Sep; 10(5):362-4. PubMed ID: 8240594
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Vlk R
J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
[TBL] [Abstract][Full Text] [Related]
14. The use of maternal plasma for prenatal RhD blood group genotyping.
Finning K; Martin P; Daniels G
Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
[TBL] [Abstract][Full Text] [Related]
15. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
Trevett TN; Moise KJ
Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
[TBL] [Abstract][Full Text] [Related]
16. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
[TBL] [Abstract][Full Text] [Related]
17. [High-throughput genotyping multiplex ligation-dependent probe amplification for assisting diagnosis in a case of anti-Di(a)-induced severe hemolytic disease of the newborn].
Ji Y; Mo C; Wei L; Zhou X; Zhang R; Zhao Y; Luo H; Wang Z; Luo G
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):234-8. PubMed ID: 22381766
[TBL] [Abstract][Full Text] [Related]
18. The low prevalence Rh antigen Be(a) (Rh36) is associated with RHCE*ce 662C>G in exon 5, which is predicted to encode Rhce 221Arg.
Hue-Roye K; O'Shea K; Gillett R; Wadsworth LD; Hume H; Barnes J; Kinney J; Hodgins K; Fuchisawa A; Lomas-Francis C; Reid M
Vox Sang; 2010 Apr; 98(3 Pt 1):e263-8. PubMed ID: 19951310
[TBL] [Abstract][Full Text] [Related]
19. Severe hemolytic disease of the newborn due to anti-Cw.
Byers BD; Gordon MC; Higby K
Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
[TBL] [Abstract][Full Text] [Related]
20. Anti-E as a cause of hemolytic disease of the newborn.
Cheepsattayakorn R; Fongsatitkul L; Chotinaruemol S; Mahawongtong M
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S1-4. PubMed ID: 9347637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
